MICHELLE DOCKRAY: Open Payments
NPI 1982343489 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 44 payments from 8 companies in 2025. Trend: 2023 $612 · 2024 $840 · 2025 $1,157
Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $303 |
| GlaxoSmithKline, LLC. | 5 | $208 |
| UCB, Inc. | 4 | $205 |
| ABBVIE INC. | 10 | $141 |
| United Therapeutics Corporation | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: BENLYSTA, Bimzelx, OTEZLA, COSENTYX, SKYRIZI, SAPHNELO, RINVOQ, EVENITY.
Industry payments across OK — which companies pay providers there.
